A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Clinical trial NCT05298683 · UNKNOWN

Trial details

NCT number: NCT05298683
Sponsor: Hellenic Society of Hematology
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Renal Impairment Neoplasms, Plasma Cell Neoplasms by Histologic Type Neoplasms Paraproteinemias Blood Protein Disorders Hematologic Diseases

Start date: 2022-05-01
Primary completion: 2025-11-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.